Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients

被引：0
|
作者：
Xiaoyi Wang
Jing Huang
Jianjun Lu
Xuemei Li
Hui Tang
Ping Shao
机构：
[1] The Second Xiangya Hospital of Central South University,Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders
[2] The Third People’s Hospital of Jiangyin City,undefined
[3] People’s Hospital of Dali Prefecture,undefined
来源：
BMC Psychiatry | / 24卷
关键词：
Risperidone; Chronic schizophrenia; Plasma concentration; polymorphism; Effect; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Statin therapy correlated CYP2D6 gene polymorphism and hyperlipidemia
    Li, Juyi
    Wang, Xiufang
    Zhang, Zhaoqing
    Zou, Jili
    Chen, Yonggang
    Wang, Xiong
    Wu, Jinhu
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (02) : 223 - 228
  • [22] QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations
    Llerena, A
    Berecz, R
    Dorado, P
    de la Rubia, A
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (02) : 189 - 193
  • [23] Clinical relevance of the CYP2D6 polymorphism for the treatment of psychiatric disorders
    Bertilsson, L
    PHARMACOGENETICS - TAILOR-MADE PHARMACOTHERAPY, 2002, 1244 : 11 - 20
  • [24] Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia
    Wang, Lei
    Yu, Lan
    Zhang, Ai-Ping
    Fang, Chao
    Du, Jing
    Gu, Niu-Fan
    Qin, Sheng-Ying
    Feng, Guo-Yin
    Li, Xing-Wang
    Xing, Qing-He
    He, Lin
    JOURNAL OF PSYCHOPHARMACOLOGY, 2007, 21 (08) : 837 - 842
  • [25] CYP2D6 genetic polymorphism and psychiatry patients' hospitalization period
    Penas-LLedo, Eva M.
    LLerena, Adrian
    BIOMARKERS IN MEDICINE, 2013, 7 (06) : 915 - 916
  • [26] THE RESPONSE TO ATYPICAL ANTIPSYCHOTIC DRUGS IN CORRELATION WITH THE CYP2D6 GENOTYPE: CLINICAL IMPLICATIONS AND PERSPECTIVES
    Nussbaum, Laura
    Gradinaru, Raluca
    Andreescu, Nicoleta
    Dumitrascu, Victor
    Tudor, Anca
    Suciu, Liana
    Stefanescu, Radu
    Puiu, Maria
    FARMACIA, 2014, 62 (06) : 1191 - 1201
  • [27] A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents
    Thomas Dodsworth
    David D. Kim
    Ric M. Procyshyn
    Colin J. Ross
    William G. Honer
    Alasdair M. Barr
    Child and Adolescent Psychiatry and Mental Health, 12
  • [28] Effects of CYP2D6 Genotype on the Pharmacokinetics, Pharmacodynamics, and Safety of Risperidone in Healthy Volunteers
    Novalbos, Jesus
    Lopez-Rodriguez, Rosario
    Roman, Manuel
    Gallego-Sandin, Sonia
    Ochoa, Dolores
    Abad-Santos, Francisco
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (05) : 504 - 511
  • [29] Risperidone metabolism in relation to CYP2D6*10 allele in Korean schizophrenic patients
    Roh, HK
    Kim, CE
    Chung, WG
    Park, CS
    Svensson, JO
    Bertilsson, L
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (09) : 671 - 675
  • [30] CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment
    Almoguera, Berta
    Riveiro-Alvarez, Rosa
    Lopez-Castroman, Jorge
    Dorado, Pedro
    Vaquero-Lorenzo, Concepcion
    Fernandez-Piqueras, Jose
    LLerena, Adrian
    Abad-Santos, Francisco
    Baca-Garcia, Enrique
    Dal-Re, Rafael
    Ayuso, Carmen
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (11) : 627 - 630
12345